Are Ultra-High Drug Prices Sustainable?

1 min read

Goodrx (NASDAQ: GDRX) recently released its list of the 10 most expensive drugs on the market. Novartis(NYSE: NVS) gene therapy Zolgensma remains at the top, but newcomers Eiger Pharmaceuticals (NASDAQ: EIGR) and Y-mAbs Therapeutics (NASDAQ: YMAB) took second and third place with Zokinvy and Danyelza, respectively. In this video from Motley Fool Live, recorded on March 15, Contributors Brian Orelli and Keith Speights discuss the high-priced drugs and whether the prices are sustainable in the long run.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Forget Dogecoin, These 3 Tech Stocks Are Better Buys Right Now

Next Story

Our April Fool’s Day Gift to You

Latest from Blog